MAHON PAUL A
SEC CIK 1231589 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS Corp | EVP, GC | 53.5K | — | $246.06M | 232 | 2021-07-01 | 2026-09-17 |
Most active insiders at UTHR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROTHBLATT MARTINE A | COB, CEO, Dir | -$863.9K | $840.04M |
| 2 | BENKOWITZ MICHAEL | Pres AND COO | — | $226.97M |
| 3 | EDGEMOND JAMES | CFO AND Treas | — | $211.57M |
| 4 | MAHON PAUL A | EVP, GC | — | $114.08M |
| 5 | SULLIVAN LOUIS W | Dir | — | $3.05M |
| 6 | PATUSKY CHRISTOPHER | Dir | — | $2.73M |
| 7 | Thompson Tommy G | Dir | — | $2.51M |
| 8 | KURZWEIL RAY | Dir | — | $2.40M |
| 9 | CAUSEY CHRISTOPHER | Dir | — | $2.33M |
| 10 | Olian Judy D. | Dir | — | $417.0K |
Transactions 232
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-24 | 2024-06-20 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | D - Sale to Iss | $308.98 | -25.0K | 36.7K | -41% | -$7.72M |
| D | 2024-06-24 | 2024-06-20 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $163.30 | +25.0K | 61.7K | +68% | +$4.08M |
| DM | 2024-04-04 | 2024-04-04 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $232.37 | -6,000 | 36.7K | -14% | -$1.39M |
| D | 2024-04-04 | 2024-04-04 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $117.76 | +6,000 | 42.7K | +16% | +$706.6K |
| DM | 2024-03-22 | 2024-03-21 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $236.45 | -6,000 | 41.6K | -13% | -$1.42M |
| D | 2024-03-22 | 2024-03-21 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $117.76 | +6,000 | 42.7K | +16% | +$706.6K |
| DM | 2024-03-07 | 2024-03-07 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $237.38 | -6,000 | 36.9K | -14% | -$1.42M |
| D | 2024-03-07 | 2024-03-07 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $117.76 | +6,000 | 42.6K | +16% | +$706.6K |
| DM | 2024-02-15 | 2024-02-15 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $215.31 | -6,000 | 41.0K | -13% | -$1.29M |
| D | 2024-02-15 | 2024-02-15 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $117.76 | +6,000 | 42.6K | +16% | +$706.6K |
| DM | 2024-02-02 | 2024-02-01 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $215.02 | -6,000 | 36.6K | -14% | -$1.29M |
| D | 2024-02-02 | 2024-02-01 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $117.76 | +6,000 | 42.6K | +16% | +$706.6K |
| DM | 2024-01-18 | 2024-01-18 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $218.72 | -6,000 | 41.2K | -13% | -$1.31M |
| D | 2024-01-18 | 2024-01-18 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $117.76 | +6,000 | 42.6K | +16% | +$706.6K |
| DM | 2024-01-05 | 2024-01-04 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $227.97 | -6,000 | 40.9K | -13% | -$1.37M |
| D | 2024-01-05 | 2024-01-04 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $117.76 | +6,000 | 42.6K | +16% | +$706.6K |
| D | 2023-12-26 | 2023-12-21 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $117.76 | +6,000 | 42.6K | +16% | +$706.6K |
| DM | 2023-12-26 | 2023-12-21 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $229.26 | -6,000 | 36.6K | -14% | -$1.38M |
| DM | 2023-12-07 | 2023-12-07 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $238.89 | -6,000 | 36.6K | -14% | -$1.43M |
| D | 2023-12-07 | 2023-12-07 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $117.76 | +6,000 | 42.6K | +16% | +$706.6K |
| DM | 2023-11-17 | 2023-11-16 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $226.60 | -6,000 | 37.5K | -14% | -$1.36M |
| D | 2023-11-17 | 2023-11-16 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $117.76 | +6,000 | 42.6K | +16% | +$706.6K |
| D | 2023-11-03 | 2023-11-02 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $117.76 | +6,000 | 42.6K | +16% | +$706.6K |
| DM | 2023-11-03 | 2023-11-02 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $225.76 | -6,000 | 36.6K | -14% | -$1.35M |
| DM | 2023-10-20 | 2023-10-19 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $225.43 | -6,000 | 37.2K | -14% | -$1.35M |
| D | 2023-10-20 | 2023-10-19 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $117.76 | +6,000 | 42.6K | +16% | +$706.6K |
| DM | 2023-10-10 | 2023-10-05 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $223.82 | -6,000 | 36.6K | -14% | -$1.34M |
| D | 2023-10-10 | 2023-10-05 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $117.76 | +6,000 | 42.6K | +16% | +$706.6K |
| DM | 2023-09-22 | 2023-09-21 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $222.19 | -6,000 | 36.9K | -14% | -$1.33M |
| D | 2023-09-22 | 2023-09-21 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $117.76 | +6,000 | 42.6K | +16% | +$706.6K |
| DM | 2023-09-08 | 2023-09-07 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $222.98 | -6,000 | 39.8K | -13% | -$1.34M |
| D | 2023-09-08 | 2023-09-07 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $117.76 | +6,000 | 42.6K | +16% | +$706.6K |
| DM | 2023-08-18 | 2023-08-17 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $229.54 | -6,000 | 38.2K | -14% | -$1.38M |
| D | 2023-08-18 | 2023-08-17 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $117.76 | +6,000 | 42.6K | +16% | +$706.6K |
| D | 2023-08-04 | 2023-08-03 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $117.76 | +6,000 | 42.6K | +16% | +$706.6K |
| DM | 2023-08-04 | 2023-08-03 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $236.25 | -6,000 | 36.9K | -14% | -$1.42M |
| D | 2023-07-24 | 2023-07-20 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $243.87 | -2,500 | 36.6K | -6% | -$609.7K |
| D | 2023-07-24 | 2023-07-20 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $120.26 | +2,500 | 39.1K | +7% | +$300.6K |
| DM | 2023-07-07 | 2023-07-06 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $215.20 | -6,000 | 37.5K | -14% | -$1.29M |
| D | 2023-07-07 | 2023-07-06 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $120.26 | +6,000 | 42.6K | +16% | +$721.6K |
| D | 2023-06-15 | 2023-06-15 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $120.26 | +6,000 | 42.6K | +16% | +$721.6K |
| DM | 2023-06-15 | 2023-06-15 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $227.78 | -6,000 | 38.9K | -13% | -$1.37M |
| DM | 2023-06-01 | 2023-06-01 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $209.11 | -6,000 | 42.2K | -12% | -$1.25M |
| D | 2023-06-01 | 2023-06-01 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $120.26 | +6,000 | 42.6K | +16% | +$721.6K |
| D | 2023-05-18 | 2023-05-18 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $120.26 | +6,000 | 42.6K | +16% | +$721.6K |
| DM | 2023-05-18 | 2023-05-18 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $214.58 | -6,000 | 36.6K | -14% | -$1.29M |
| DM | 2023-05-04 | 2023-05-04 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $215.82 | -6,000 | 36.6K | -14% | -$1.29M |
| D | 2023-05-04 | 2023-05-04 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $120.26 | +6,000 | 42.6K | +16% | +$721.6K |
| DM | 2023-04-20 | 2023-04-20 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $223.96 | -6,000 | 36.6K | -14% | -$1.34M |
| D | 2023-04-20 | 2023-04-20 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $120.26 | +6,000 | 42.6K | +16% | +$721.6K |
| DM | 2023-04-07 | 2023-04-06 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $232.79 | -6,000 | 41.6K | -13% | -$1.40M |
| D | 2023-04-07 | 2023-04-06 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $120.26 | +6,000 | 42.6K | +16% | +$721.6K |
| DM | 2023-03-17 | 2023-03-16 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $214.39 | -6,000 | 38.3K | -14% | -$1.29M |
| D | 2023-03-17 | 2023-03-16 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $120.26 | +6,000 | 42.6K | +16% | +$721.6K |
| DM | 2023-03-02 | 2023-03-02 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $242.57 | -6,000 | 36.9K | -14% | -$1.46M |
| D | 2023-03-02 | 2023-03-02 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $120.26 | +6,000 | 42.4K | +16% | +$721.6K |
| DM | 2023-02-16 | 2023-02-16 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $249.16 | -6,000 | 38.2K | -14% | -$1.49M |
| D | 2023-02-16 | 2023-02-16 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $120.26 | +6,000 | 42.4K | +16% | +$721.6K |
| DM | 2023-02-02 | 2023-02-02 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $254.63 | -6,000 | 36.4K | -14% | -$1.53M |
| D | 2023-02-02 | 2023-02-02 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $120.26 | +6,000 | 42.4K | +16% | +$721.6K |
| D | 2023-01-19 | 2023-01-19 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $120.26 | +6,000 | 42.4K | +16% | +$721.6K |
| DM | 2023-01-19 | 2023-01-19 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $258.95 | -6,000 | 41.2K | -13% | -$1.55M |
| DM | 2023-01-05 | 2023-01-05 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $273.82 | -6,000 | 37.1K | -14% | -$1.64M |
| D | 2023-01-05 | 2023-01-05 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $120.26 | -6,000 | 42.4K | -12% | -$721.6K |
| DM | 2022-12-16 | 2022-12-15 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale | $196.31 | -12.0K | 39.7K | -23% | -$2.36M |
| DM | 2022-12-01 | 2022-12-01 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $277.65 | -6,000 | 41.7K | -13% | -$1.67M |
| D | 2022-12-01 | 2022-12-01 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $120.26 | +6,000 | 42.4K | +16% | +$721.6K |
| DM | 2022-11-17 | 2022-11-17 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $259.05 | -6,000 | 40.3K | -13% | -$1.55M |
| D | 2022-11-17 | 2022-11-17 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $120.26 | +6,000 | 42.4K | +16% | +$721.6K |
| DM | 2022-11-04 | 2022-11-03 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $257.08 | -6,000 | 41.2K | -13% | -$1.54M |
| D | 2022-11-04 | 2022-11-03 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $120.26 | +6,000 | 42.4K | +16% | +$721.6K |
| DM | 2022-10-24 | 2022-10-20 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $216.68 | -6,000 | 36.4K | -14% | -$1.30M |
| D | 2022-10-24 | 2022-10-20 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $120.26 | +6,000 | 42.4K | +16% | +$721.6K |
| DM | 2022-10-06 | 2022-10-06 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $209.26 | -6,000 | 36.4K | -14% | -$1.26M |
| D | 2022-10-06 | 2022-10-06 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $120.26 | +6,000 | 42.4K | +16% | +$721.6K |
| DM | 2022-09-26 | 2022-09-22 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $203.34 | -6,000 | 40.2K | -13% | -$1.22M |
| D | 2022-09-26 | 2022-09-22 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $120.26 | +6,000 | 42.4K | +16% | +$721.6K |
| D | 2022-08-04 | 2022-08-04 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $225.81 | -4,552 | 36.4K | -11% | -$1.03M |
| D | 2022-08-04 | 2022-08-04 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $111.00 | +4,552 | 40.9K | +13% | +$505.3K |
| D | 2022-07-22 | 2022-07-21 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $111.00 | +6,000 | 42.4K | +16% | +$666.0K |
| DM | 2022-07-22 | 2022-07-21 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $226.27 | -6,000 | 42.0K | -13% | -$1.36M |
| DM | 2022-07-08 | 2022-07-07 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $242.04 | -6,000 | 37.1K | -14% | -$1.45M |
| D | 2022-07-08 | 2022-07-07 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $111.00 | +6,000 | 42.4K | +16% | +$666.0K |
| D | 2022-06-17 | 2022-06-16 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $111.00 | +6,000 | 42.4K | +16% | +$666.0K |
| DM | 2022-06-17 | 2022-06-16 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $215.58 | -6,000 | 36.4K | -14% | -$1.29M |
| DM | 2022-06-03 | 2022-06-02 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $223.86 | -6,000 | 39.6K | -13% | -$1.34M |
| D | 2022-06-03 | 2022-06-02 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $111.00 | +6,000 | 42.4K | +16% | +$666.0K |
| DM | 2022-05-20 | 2022-05-19 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $183.43 | -6,000 | 36.4K | -14% | -$1.10M |
| D | 2022-05-20 | 2022-05-19 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $111.00 | +6,000 | 42.4K | +16% | +$666.0K |
| D | 2022-05-06 | 2022-05-05 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $111.00 | +6,000 | 42.4K | +16% | +$666.0K |
| DM | 2022-05-06 | 2022-05-05 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $190.65 | -6,000 | 36.4K | -14% | -$1.14M |
| DM | 2022-04-22 | 2022-04-21 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $189.18 | -6,000 | 36.4K | -14% | -$1.14M |
| D | 2022-04-22 | 2022-04-21 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $111.00 | +6,000 | 42.5K | +16% | +$666.0K |
| D | 2022-04-08 | 2022-04-07 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $111.00 | +6,000 | 42.5K | +16% | +$666.0K |
| DM | 2022-04-08 | 2022-04-07 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $185.51 | -6,000 | 37.7K | -14% | -$1.11M |
| DM | 2022-03-18 | 2022-03-17 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $182.41 | -6,000 | 38.1K | -14% | -$1.09M |
| D | 2022-03-18 | 2022-03-17 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $111.00 | +6,000 | 42.5K | +16% | +$666.0K |
| D | 2022-03-04 | 2022-03-03 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $111.00 | +6,000 | 42.4K | +16% | +$666.0K |
| DM | 2022-03-04 | 2022-03-03 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $174.12 | -6,000 | 36.4K | -14% | -$1.04M |
| DMA | 2022-03-04 | 2022-01-06 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $192.46 | -6,000 | 42.0K | -12% | -$1.15M |
Purchase Sale Sale after option exercise All abbreviations